Ophthalmology Education and CME

Select a Specialty

J535
CME

ROCK-solid Inhibition in Glaucoma Therapy

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Expiration Date: 3/17/2020
Credit Type(s): CME | Credit: 0.75

The medical management of glaucoma is primarily focused on lessening intraocular pressure (IOP) by reducing aqueous humor formation or improving the drainage of aqueous…

go to activity»
Retina 2019: What’s New in Tie2?
CME

Retina 2019: What’s New in Tie2?

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 2/20/2020
Credit Type(s): CME | Credit: 0.75

The integration of intravitreal anti-vascular endothelial growth factor (VEGF) therapy into management algorithms for the treatment of patients with neovascular retinal…

go to activity»
Progressive Pathways in Treating Neovascular Retinal Disease: Exploring Tie2
CME

Progressive Pathways in Treating Neovascular Retinal Disease: Exploring Tie2

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 1/14/2020
Credit Type(s): CME | Credit: 1.25

The integration of intravitreal anti-vascular endothelial growth factor (VEGF) therapy into management algorithms for the treatment of patients with neovascular retinal…

go to activity»
Visualizing the Latest In DME Management: Implementing Novel Treatment Strategies to Improve Patient Outcomes
CMECE

Visualizing the Latest In DME Management: Implementing Novel Treatment Strategies to Improve Patient Outcomes

Supported by an educational grant from Allergan Inc.

Expiration Date: 12/17/2019
Credit Type(s): CME / Participation | Credit: 0.75

Despite the critical role of vascular endothelial growth factor (VEGF) inhibitors in managing patients with diabetic macular edema (DME), up to half of patients fail to…

go to activity»
Boosting Visual Outcomes with Proven Trifocal IOL Technology

Practice Profiles: Boosting Visual Outcomes with Proven Trifocal IOL Technology

This activity is sponsored by Alcon Laboratories, Inc.

December 18, 2018

We profiled several European KOLs about their experience with the the AcrySof IQ PanOptix trifocal IOL, a popular alternative to multifocal and monofocal IOLs….

go to activity»
J555-HEA002
CME

Cataract and Refractive 360—Fundamentals, Techniques, & Technology; Volume 3, Number 4

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Carl Zeiss Meditec, Inc.; and J & J Vision.

Expiration Date: 11/25/2019
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery involves a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, which…

go to activity»
A Clearer Focus: Moving Forward to Improve the Management of Ocular Surface Disease.
CME

A Clearer Focus: Moving Forward to Improve the Management of Ocular Surface Disease

This activity is supported by an educational grant from Shire.

Expiration Date: 2/27/2020
Credit Type(s): CME | Credit: 0.75

Ocular surface disease (OSD) encompasses several disorders which include dry eye disease, blepharitis, meibomian gland dysfunction, ocular allergy, and conjunctivitis…

go to activity»
J843
CME

Long-term Management of Neovascular AMD: Meeting the Need for Improvement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 2/13/2020
Credit Type(s): CME | Credit: 0.75

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment. As prevalence of AMD continues to increase, it is estimated…

go to activity»
Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care
CME

Multidisciplinary Perspectives in Giant Cell Arteritis: A Team-based Approach for Improved Quality of Care

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 12/1/2019
Credit Type(s): CME | Credit: 1.25

Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. If left untreated, patients with GCA are at increased risk for various short-…

go to activity»
Ocular Surface Diseases, Disorders, and Dysfunctions®, Volume 4, Number 3
COPECME

Ocular Surface Diseases, Disorders, and Dysfunctions®, Volume 4, Number 3

This activity is supported by an educational grant from Shire.

Expiration Date: 12/1/2019
Credit Type(s): CME / COPE | Credit: 1.25

Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to differentially diagnose and is frequently…

go to activity»
J429-HEA001
CME

Medical Management of Glaucoma: A Closer Look at the Role of Nitric Oxide

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 11/29/2019
Credit Type(s): CME | Credit: 0.75

Glaucoma is a leading cause of blindness worldwide, with an estimated 70 million people living with this condition. Many individuals with glaucoma remain at risk for…

go to activity»
Rapid Response from Chicago: Advances in the Long-term Management of Non-infectious Uveitis
CME

Rapid Response from Chicago: Advances in the Long-term Management of Non-infectious Uveitis

This activity is supported by educational grants from AbbVie, Inc.; Mallinckrodt Pharmaceuticals; and Santen Inc.

Expiration Date: 11/7/2019
Credit Type(s): CME | Credit: 0.75

Non-infectious uveitis is a leading cause of preventable blindness worldwide. To avert potential severe vision loss, timely diagnosis and the initiation of an effective…

go to activity»